InMed Pharmaceuticals Q3 EPS $(0.02), Same YoY

InMed Pharmaceuticals (TSX:IN) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year.

Benzinga · 11/08/2019 13:03

InMed Pharmaceuticals (TSX:IN) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last year.